Categories: HealthcareNews

CathVision to Exhibit the Latest Advancements in Electrophysiology at Heart Rhythm Society 2025 in San Diego

COPENHAGEN, Denmark, April 21, 2025 /PRNewswire/ — CathVision, a leader in advanced cardiac electrophysiology (EP) technology, is pleased to announce its participation and exhibition at the Heart Rhythm Society (HRS) 2025 Annual Scientific Sessions at the San Diego Convention Center in San Diego, California. The premier scientific event in electrophysiology, scheduled from April 24th – 27th, 2025, will host global EP specialists, healthcare professionals, and industry leaders, showcasing groundbreaking research and innovative technologies shaping the future of cardiac care.

At HRS 2025, two significant achievements will be presented that highlight the capabilities of our state-of-the-art EP solutions:

  • Thursday April 24th 5.00-6.30pm PDT: Measurement of Unipolar Residual Signals Following Pulsed-Field Ablation (PFA), from Mt. Sinai Hospital (New York City), presented by Dr. Keita Watanabe.
  • Friday April 25th 3.30-5.30pm PDT: Detection of Electrically Silent Gaps Using a Unipolar Local Energy Algorithm in Pulsed-Field and RF Ablation, from OLV Aalst (Belgium), presented by Dr. Tom De Potter.

CathVision will seek to engage visitors in expert discussions and technology demonstrations at their booth (#1341), allowing attendees to explore innovative EP technologies. The CathVision team, including senior executives and clinical experts, will be present to discuss clinical applications, procedural efficiencies, and the promising impacts of their latest research findings.

“We’re proud to introduce our latest scientific advancements at HRS 2025, reinforcing our commitment to transforming electrophysiological care,” said Mads Matthiesen, CEO at CathVision. “Our emerging, cutting-edge algorithms and precise measurement techniques can help enhance clinicians’ ability to optimize ablation outcomes, ultimately benefiting patients worldwide.”

About CathVision

CathVision is a medical technology company dedicated to advancing cardiac electrophysiology through innovative solutions that deliver unmatched signal clarity and actionable insights during catheter ablation procedures through its ECGenius System. Combining artificial intelligence, advanced algorithms, and intuitive user interfaces in its CARDIALYTICS suite of modules, CathVision empowers clinicians to make more informed clinical decisions, leading to improved patient outcomes. Founded in 2013, CathVision is headquartered in Denmark, and its U.S. office is in Minnesota.

For more information, visit www.cathvision.com or follow CathVision on LinkedIn and Twitter. To meet directly with CathVision at HRS 2025, please visit booth #1341.

View original content:https://www.prnewswire.com/news-releases/cathvision-to-exhibit-the-latest-advancements-in-electrophysiology-at-heart-rhythm-society-2025-in-san-diego-302433242.html

SOURCE CathVision

Staff

Recent Posts

The State of HTM, 2025: Report Signals Changing Health Tech Workforce

Biomedical Engineers, Clinical Engineers, Others Weigh in on State of the Health Care IndustryArlington, Virginia--(Newsfile…

4 minutes ago

Standard Process Launches Cultivate, a New Practitioner Symposium Advancing Whole-Food Nutrition and Healthy Aging

Two immersive 2026 events in Seattle and Boston will offer up to 12 CE credits,…

56 minutes ago

Vericel Announces Preliminary 2025 Financial Results and Business Updates

Total Revenue Expected to be $276 Million  MACI Revenue Expected to be $239.5 Million Fourth…

57 minutes ago

Stroke Experts Challenge “90-Day Recovery” Myth: New Research Shows Patients Need Long-Term Care

Study published by Centre for Neuro Skills researchers in Brain Injury journal argues current insurance…

57 minutes ago

Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed® in Community-Based Care

Partnership enables broader adoption of FemaSeed through a trusted community health provider serving a large,…

57 minutes ago

IMDX Supports AST and ASHI STAR Working Group’s Call for Decentralized Transplant Monitoring

American Journal of Transplantation position paper also highlights value of absolute quantification of dd-cfDNA as…

57 minutes ago